These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 7525096
1. Comparative genotoxicity of 2,3'-O-cyclocytidine, beta-xylocytidine and 1-beta-D-arabinofuranosylcytosine in human tumor cell lines. Mirzayans R, Cubitt S, Enns L, Karimian K, Radatus B, Hirani-Hojatti S, Murthy K, Paterson MC. Carcinogenesis; 1994 Oct; 15(10):2319-24. PubMed ID: 7525096 [Abstract] [Full Text] [Related]
2. Effect of DNA polymerase inhibitors on repair of gamma ray-induced DNA damage in proliferating (intact versus permeable) human fibroblasts: evidence for differences in the modes of action of aphidicolin and 1-beta-D-arabinofuranosylcytosine. Mirzayans R, Enns L, Cubitt S, Karimian K, Radatus B, Paterson MC. Biochim Biophys Acta; 1994 Oct 21; 1227(1-2):92-100. PubMed ID: 7918688 [Abstract] [Full Text] [Related]
3. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells. Bouffard DY, Jolivet J, Leblond L, Hamelin B, Ouellet F, Barbeau S, Richard A, Gourdeau H. Cancer Chemother Pharmacol; 2003 Dec 21; 52(6):497-506. PubMed ID: 12955470 [Abstract] [Full Text] [Related]
4. Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells. Grem JL, Geoffroy F, Politi PM, Cuddy DP, Ross DD, Nguyen D, Steinberg SM, Allegra CJ. Mol Pharmacol; 1995 Aug 21; 48(2):305-15. PubMed ID: 7651364 [Abstract] [Full Text] [Related]
5. Synergistic effect of aphidicolin and 1-beta-D-arabinofuranosylcytosine on the repair of gamma-ray-induced DNA damage in normal human fibroblasts. Mirzayans R, Andrais B, Paterson MC. Int J Radiat Biol; 1992 Oct 21; 62(4):417-25. PubMed ID: 1357055 [Abstract] [Full Text] [Related]
6. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine. Niitsu N, Ishii Y, Matsuda A, Honma Y. Cancer Res; 2001 Jan 01; 61(1):178-85. PubMed ID: 11196157 [Abstract] [Full Text] [Related]
7. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line. Verschuur AC, Van Gennip AH, Leen R, Voûte PA, Brinkman J, Van Kuilenburg AB. Int J Cancer; 2002 Apr 01; 98(4):616-23. PubMed ID: 11920624 [Abstract] [Full Text] [Related]
8. Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity. Bierau J, Van Gennip AH, Leen R, Helleman J, Caron HN, Van Kuilenburg AB. Int J Cancer; 2003 Jan 20; 103(3):387-92. PubMed ID: 12471622 [Abstract] [Full Text] [Related]
9. Induction and repair of DNA strand breaks and 1-beta-D-arabinofuranosylcytosine-detectable sites in 40-75 kVp X-irradiated compared to 60Co gamma-irradiated human cell lines. Mirzayans R, Waters R, Paterson MC. Radiat Res; 1988 Apr 20; 114(1):168-85. PubMed ID: 3353503 [Abstract] [Full Text] [Related]
10. Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line. Verschuur AC, Brinkman J, Van Gennip AH, Leen R, Vet RJ, Evers LM, Voûte PA, Van Kuilenburg AB. Leuk Res; 2001 Oct 20; 25(10):891-900. PubMed ID: 11532523 [Abstract] [Full Text] [Related]
11. Metronidazole enhances the cytotoxic synergism produced by the combination of 1-beta-arabinofuranosylcytosine and cis-diamminedichloroplatinum. Trujillo JM, Yang LY, Gercovich G, Su YZ, Lee J. Anticancer Res; 1989 Oct 20; 9(6):1751-6. PubMed ID: 2627125 [Abstract] [Full Text] [Related]
12. Toxic interaction between hydroxyurea and 1-beta-D-arabino-furanosylcytosine on the DNA of a human hepatoma cell line (HEPG2). Severin I, Padieu M, Lhuguenot JC, Chagnon MC. Toxicol Lett; 2003 Dec 10; 145(3):303-11. PubMed ID: 14580901 [Abstract] [Full Text] [Related]
13. Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity. Gourdeau H, Bibeau L, Ouellet F, Custeau D, Bernier L, Bowlin T. Cancer Chemother Pharmacol; 2001 Mar 10; 47(3):236-40. PubMed ID: 11320667 [Abstract] [Full Text] [Related]
14. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines. Ramilo-Torno LV, Avramis VI. Cancer Chemother Pharmacol; 1995 Mar 10; 35(3):191-9. PubMed ID: 7805176 [Abstract] [Full Text] [Related]
15. Comparative studies on repair inhibition by araA, araC and aphidicolin of radiation induced DNA and chromosome damage in rodent cells: comparison with fixation of PLD. Iliakis G, Pantelias G, Okayasu R, Seaner R. Int J Radiat Oncol Biol Phys; 1989 May 10; 16(5):1261-5. PubMed ID: 2497095 [Abstract] [Full Text] [Related]
16. Evaluation of synergism of drugs cis-diamminedichloroplatinum (II) and arabinosylcytosine on the level of chemical interaction with DNA and on the growth of mouse leukemia. Rauko P, Novotný L, Reichelová V, Balázová E. Gen Pharmacol; 1991 May 10; 22(5):805-10. PubMed ID: 1761184 [Abstract] [Full Text] [Related]
17. Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine. Someya H, Waud WR, Parker WB. Cancer Chemother Pharmacol; 2006 Jun 10; 57(6):772-80. PubMed ID: 16180016 [Abstract] [Full Text] [Related]
18. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60). Vilpo JA, Vilpo LM. Cancer Res; 1988 Jun 01; 48(11):3117-22. PubMed ID: 3163271 [Abstract] [Full Text] [Related]
19. Effects of protein kinase C inhibitor, staurosporine derivative CGP 41 251, on cell cycle, DNA synthesis and drug uptake in neoplastic cell lines. Sedlak J, Hunakova L, Duraj J, Chorvath B, Novotny L. Anticancer Drugs; 1995 Feb 01; 6(1):70-6. PubMed ID: 7756686 [Abstract] [Full Text] [Related]
20. Faulty DNA polymerase delta/epsilon-mediated excision repair in response to gamma radiation or ultraviolet light in p53-deficient fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome. Mirzayans R, Enns L, Dietrich K, Barley RD, Paterson MC. Carcinogenesis; 1996 Apr 01; 17(4):691-8. PubMed ID: 8625479 [Abstract] [Full Text] [Related] Page: [Next] [New Search]